Category: PMN Press Releases

Jul 2

Access Advance Welcomes Global Technology Leaders as Licensees and Licensors to New Video Distribution Patent Pool

Access Advance manages and administers the HEVC Advance Patent Pool for licensing over 25,500 patents essential to H.265/HEVC technology and the VVC Advance Patent Pool for licensing essential patents to VVC/H.266 technology. The company’s Multi-Codec Bridging Agreement provides eligible licensees with a single discounted royalty rate structure for licensees participating in both the HEVC Advance […]
Jul 1

Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

This news release includes forward-looking statements within the meaning of applicable securities laws. Except for statements of historical fact, any information contained in this news release may be a forward‐looking statement that reflects the Company’s current views about future events and are subject to known and unknown risks, uncertainties, assumptions and other factors that may […]
Jul 1

Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ […]
Jun 29

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

ROCKVILLE, Md. & EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it will host a webcast and conference call on June 30, 2025, at 8:30 a.m. ET to discuss AUR200 Phase 1 study results. The link to the webcast is available here. To join the conference call, please dial 877-407-9170/+1 201-493-6756. Click […]
Jun 27

Axis Auto Finance Inc. Announces Completion of Going Private Transaction

Further information on the Company can be found at: https://www.axisfinancegroup.com/investors-press-releases/Forward-Looking and Cautionary Statements Certain information set out in this news release constitutes forward-looking information. Forward looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “plan”, “continue”, “estimate”, “expect”, “may”, “will”, “intend”, “could”, “might”, “should”, “believe” and similar […]
Jun 19

CUPE 2073 and OCEU/CUPE 1750 to Rally Outside MPP Chris Scott’s Office

“The members of 2073 and 1750 have tried everything to get back to the table,” said Mara Waern, President of CUPE 2073. “The fact that our employers won’t bargain, won’t consider our proposals, and in the case of Canadian Hearing Services, won’t make a proposal of their own, shows a complete disregard for our members […]
Jun 18

OCEU/CUPE 1750 President to Join Barrie Picket Line as WSIB Strike Enters Fourth Week

BARRIE, Ontario — As the strike by Workplace Safety and Insurance Board (WSIB) workers stretches into its fourth week, Harry Goslin, President of the Ontario Compensation Employees Union (OCEU/CUPE 1750), will join the picket line in Barrie on Wednesday, June 18 at 10:00 a.m., to support members in their fight for a fair contract, safer […]
Jun 18

DNP to Take Controlling-Stake in Laxton

Laxton develops ID authentication services using biometric information, primarily for governments in emerging countries and regions, such as Africa, and has a track record of implementation in over 50 countries and regions around the world. The company provides services that combine mobility, robustness, and security by housing ID registration and authentication devices and card printers […]
Jun 17

 ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering

This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the Company’s business, the Company’s ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, receipt of TSXV final acceptance, closing […]